Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1992-10-22
|
| pubmed:abstractText |
Immunotoxins directed against a membrane marker of cell proliferation, transferrin receptor, were investigated to inhibit the growth of retinal pigment epithelial (RPE) cells in proliferative vitreoretinopathy (PVR). We undertook an immunocytological study in specimens of vitreous, subretinal fluid, and epiretinal membranes from patients with PVR to address the expression of transferrin receptor by proliferating pigment epithelial cells during the course of PVR and in normal human ocular structures. Thirty four specimens of vitreous and subretinal fluid, as well as seven epiretinal membranes, were immunocytologically examined using monoclonal antibodies to transferrin receptor. They showed a strong expression of this marker by a large majority of the cells in these two periretinal fluids (mean percentages 80 and 91% in vitreous and subretinal fluid, respectively). In contrast, only a few cells within epiretinal membranes were found to express transferrin receptor. In normal human eye sections conjunctival and corneal epithelial cells, subcapsular epithelium of the lens strongly expressed transferrin receptor, whereas RPE cells remained negative to antitransferrin receptor antibodies. A few iris or ciliary pigment epithelial cells reacted weakly. Thus, this study shows that most intravitreal and subretinal fluid proliferating cells strongly express transferrin receptor on their surface. Also confirmed is that immunotoxins to this membrane antigen could constitute potentially useful therapeutic agents in PVR.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0146-0404
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
33
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2822-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1382045-Adult,
pubmed-meshheading:1382045-Aged,
pubmed-meshheading:1382045-Aged, 80 and over,
pubmed-meshheading:1382045-Antibodies, Monoclonal,
pubmed-meshheading:1382045-Cell Membrane,
pubmed-meshheading:1382045-Conjunctiva,
pubmed-meshheading:1382045-Epithelium,
pubmed-meshheading:1382045-Exudates and Transudates,
pubmed-meshheading:1382045-Eye Diseases,
pubmed-meshheading:1382045-Fluorescent Antibody Technique,
pubmed-meshheading:1382045-Humans,
pubmed-meshheading:1382045-Keratins,
pubmed-meshheading:1382045-Lens, Crystalline,
pubmed-meshheading:1382045-Middle Aged,
pubmed-meshheading:1382045-Pigment Epithelium of Eye,
pubmed-meshheading:1382045-Receptors, Transferrin,
pubmed-meshheading:1382045-Retinal Detachment,
pubmed-meshheading:1382045-Retinal Diseases,
pubmed-meshheading:1382045-Vitreous Body
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
|
| pubmed:affiliation |
Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
|
| pubmed:publicationType |
Journal Article
|